- Brief Communication
- Published:
TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis
- Edor Kabashi1 na1,
- Paul N Valdmanis1 na1,
- Patrick Dion1,
- Dan Spiegelman1,
- Brendan J McConkey2,
- Christine Vande Velde1,
- Jean-Pierre Bouchard3,
- Lucette Lacomblez4,
- Ksenia Pochigaeva4,
- Francois Salachas4,
- Pierre-Francois Pradat4,
- William Camu5,
- Vincent Meininger4,
- Nicolas Dupre1,3 &
- …
- Guy A Rouleau1
Nature Geneticsvolume 40, pages572–574 (2008)Cite this article
9888Accesses
1412Citations
15Altmetric
Abstract
Recently, TDP-43 was identified as a key component of ubiquitinated aggregates in amyotrophic lateral sclerosis (ALS), an adult-onset neurological disorder that leads to the degeneration of motor neurons. Here we report eight missense mutations in nine individuals—six from individuals with sporadic ALS (SALS) and three from those with familial ALS (FALS)—and a concurring increase of a smaller TDP-43 product. These findings further corroborate that TDP-43 is involved in ALS pathogenesis.
This is a preview of subscription content,access via your institution
Access options
Subscription info for Japanese customers
We have a dedicated website for our Japanese customers. Please go tonatureasia.com to subscribe to this journal.
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
¥ 4,980
Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others
References
Lansbury, P.T. & Lashuel, H.A.Nature443, 774–779 (2006).
Arai, T. et al.Biochem. Biophys. Res. Commun.351, 602–611 (2006).
Mackenzie, I.R. et al.Ann. Neurol.61, 427–434 (2007).
Neumann, M. et al.Science314, 130–133 (2006).
Strong, M.J. et al.Mol. Cell. Neurosci.35, 320–327 (2007).
Gijselinck, I. et al.Neurobiol. Aging (in press).
Greenway, M.J. et al.Nat. Genet.38, 411–413 (2006).
Frey, S., Richter, R.P. & Gorlich, D.Science314, 815–817 (2006).
Buratti, E. et al.J. Biol. Chem.280, 37572–37584 (2005).
Ou, S.H., Wu, F., Harrich, D., Garcia-Martinez, L.F. & Gaynor, R.B.J. Virol.69, 3584–3596 (1995).
Forman, M.S., Trojanowski, J.Q. & Lee, V.M.Curr. Opin. Neurobiol.17, 548–555 (2007).
Wang, H.Y., Wang, I.F., Bose, J. & Shen, C.K.Genomics83, 130–139 (2004).
Wang, I.F., Reddy, N.M. & Shen, C.K.Proc. Natl. Acad. Sci. USA99, 13583–13588 (2002).
Amador-Ortiz, C. et al.Ann. Neurol.61, 435–445 (2007).
Filimonenko, M. et al.J. Cell Biol.179, 485–500 (2007).
Acknowledgements
We would like to thank all the families involved in this study. We also thank M. Benard, I. Thibault and P. Provencher for sample collection and organization, M. D'Amour and D. Brunet for providing access to their patients and A. Dyck and J. St-Onge for technical support. G.A.R. is funded by the Canadian Institutes of Health Research (CIHR), Muscular Dystrophy Association USA and ALS Association (ALSA), E.K. by ALS Canada and CIHR, N.D. by CIHR, P.N.V. by the Fonds de Recherche en Sante Quebec (FRSQ) and V.M. by the Association Francaise contre les Myopathies France (AMF) and the Association pour la Recherche sur la Sclerose Laterale Amyotrophique (ARS).
Author information
Edor Kabashi and Paul N Valdmanis: These authors contributed equally to this work.
Authors and Affiliations
and Department of Medicine, Center of Excellence in Neuromics, Centre Hospitalier de l'Universite de Montreal, University of Montreal, Montreal, H2L4MI, Quebec, Canada
Edor Kabashi, Paul N Valdmanis, Patrick Dion, Dan Spiegelman, Christine Vande Velde, Nicolas Dupre & Guy A Rouleau
Department of Biology, University of Waterloo, 200 University Avenue West, Waterloo, N2L 3G1, Ontario, Canada
Brendan J McConkey
Faculty of Medicine, Laval University, Centre Hospitalier Affilié Universitaire de Québec – Enfant-Jesus Hospital, Quebec, G1J1Z4, Canada
Jean-Pierre Bouchard & Nicolas Dupre
Division Paul Castaigne, Fédération des maladies du système nerveux, Hôpital de la Salpêtrière, Paris, 75651, France
Lucette Lacomblez, Ksenia Pochigaeva, Francois Salachas, Pierre-Francois Pradat & Vincent Meininger
Unité de Neurologie Comportementale et Dégénérative, Institute of Biology, Montpellier, 34967, France
William Camu
- Edor Kabashi
Search author on:PubMed Google Scholar
- Paul N Valdmanis
Search author on:PubMed Google Scholar
- Patrick Dion
Search author on:PubMed Google Scholar
- Dan Spiegelman
Search author on:PubMed Google Scholar
- Brendan J McConkey
Search author on:PubMed Google Scholar
- Christine Vande Velde
Search author on:PubMed Google Scholar
- Jean-Pierre Bouchard
Search author on:PubMed Google Scholar
- Lucette Lacomblez
Search author on:PubMed Google Scholar
- Ksenia Pochigaeva
Search author on:PubMed Google Scholar
- Francois Salachas
Search author on:PubMed Google Scholar
- Pierre-Francois Pradat
Search author on:PubMed Google Scholar
- William Camu
Search author on:PubMed Google Scholar
- Vincent Meininger
Search author on:PubMed Google Scholar
- Nicolas Dupre
Search author on:PubMed Google Scholar
- Guy A Rouleau
Search author on:PubMed Google Scholar
Contributions
E.K. and P.N.V. generated the data, conducted the data analysis, wrote the manuscript and led the project; P.D. participated in the data analysis and review of the manuscript; E.K. and P.D. conducted the functional analysis of lymphoblastoid cell lines derived from individuals with ALS; P.N.V. conducted haplotype and performed 3D modelling; D.S. performed sequence and data analysis; B.J.M. conducted bioinformatic analysis of mutations and reviewed the manuscript; C.V.V. performed functional analysis and reviewed the manuscript. J.-P.B., L.L., K.P., F.S., P.-F.P., W.C., V.M. and N.D. conducted neurological evaluation and family history of individuals with ALS and reviewed the manuscript. G.A.R. conducted neurological evaluation of individuals with ALS, participated in the data analysis, reviewed the manuscript and supervised the project.
Corresponding author
Correspondence toGuy A Rouleau.
Supplementary information
Supplementary Text and Figures
Supplementary Tables 1–4, Supplementary Figures 1 and 2, Supplementary Note and Supplementary Methods (PDF 239 kb)
Rights and permissions
About this article
Cite this article
Kabashi, E., Valdmanis, P., Dion, P.et al.TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis.Nat Genet40, 572–574 (2008). https://doi.org/10.1038/ng.132
Received:
Accepted:
Published:
Issue date:
Share this article
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative
This article is cited by
A novel gene, TARDBP, and the protein it encodes can predict glioma patient prognosis and establish a prediction model
- Xu Fang
- Fan Wu
- Chen Jiang
BMC Neurology (2023)
TDP-43 forms amyloid filaments with a distinct fold in type A FTLD-TDP
- Diana Arseni
- Renren Chen
- Benjamin Ryskeldi-Falcon
Nature (2023)
Widespread CNS pathology in amyotrophic lateral sclerosis homozygous for the D90A SOD1 mutation
- Karin M. Forsberg
- Karin S. Graffmo
- Peter M. Andersen
Acta Neuropathologica (2023)
Phase separation of low-complexity domains in cellular function and disease
- Jiwon Lee
- Hana Cho
- Ilmin Kwon
Experimental & Molecular Medicine (2022)
Structure of pathological TDP-43 filaments from ALS with FTLD
- Diana Arseni
- Masato Hasegawa
- Benjamin Ryskeldi-Falcon
Nature (2022)


